Overview

Study of the Effects of Osmotic-Release Oral System (OROS) Methylphenidate (Concerta) on Attention and Memory

Status:
Completed
Trial end date:
2008-06-01
Target enrollment:
Participant gender:
Summary
This study investigates whether OROS-methylphenidate improves performance on different aspects of attention and memory in children with Attention-Deficit Hyperactivity Disorder (ADHD).
Phase:
Phase 4
Details
Lead Sponsor:
Children's Hospital of Philadelphia
Collaborator:
Ortho-McNeil Janssen Scientific Affairs, LLC
Treatments:
Methylphenidate